Clinical trial
STAT3 in T Cells: At The Crossroads of Inflammation and Cancer
NCT01663571 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- STAT3 in T Cells: At The Crossroads of Inflammation and Cancer
- Lead sponsor
- NYU Langone Health
- Phase
- Observational
- Overall status
- Terminated
- Start date
- May 1, 2012
- Completion date
- November 21, 2016
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cutaneous t cell lymphoma